Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability
Table 8
Stability study data for the formulation at initial, after 0.5, 1, 2, 3, and 6 months are expressed as mean ± SD .